| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.42 | 1e-09 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.39 | 1e-08 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-05 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |